ivd industry Archives - The Dark Intelligence Group

TAG:

ivd industry

Biggest IVD Manufacturers Report Robust Third Quarter Earnings

By Robert Michel | From the Volume XXV No. 15 – October 22, 2018 Issue

In a time of shrinking lab budgets and falling prices for lab tests in the United States, how are the larger in vitro diagnostic (IVD) manufacturers doing? A look at third-quarter financial reports provides useful insights as to which segments within the IVD industry are doing better than ot…

More IVD Consolidation as Danaher Acquires Iris

By Joseph Burns | From the Volume XIX No. – October 8, 2012 Issue

CEO SUMMARY: Danaher Corporation continues to fuel growth by continually acquiring in vitro diagnostics (IVD) companies. Its latest purchase is Iris International, which manufactures automated urine microscopy systems. Danaher also has $5 billion available that it could spend in the next …

September 13, 2010 “Intelligence: Late Breaking Lab News”

By Robert Michel | From the Volume XVII No. 13 – September 13, 2010 Issue

Researchers at North Carolina State University are developing a method that might make it possible to diagnose and treat cancer through the use of special microneedles they developed. NCSU researchers use the microneedles to deliver nanoscale dyes based on quantum dots to locations u…

Olympus Diagnostics Unit Sold to Beckman Coulter

By Robert Michel | From the Volume XVI No. 4 – March 16, 2009 Issue

CEO SUMMARY: For Beckman Coulter, the opportunity to acquire the diagnostics business of Olympus Corporation was compelling for at least two reasons. One, the chemistry and automation products of both companies are quite complementary. Two, in a steadily-consolidating in vitro di…

Busy Year Demonstrated By Top Ten Lab Stories

By Robert Michel | From the Volume XIV No. 17 – December 10, 2007 Issue

CEO SUMMARY: As it turns out, 2007 has been an action-packed year with lots of events, plenty of changes, and the promise of even faster evolution across all sectors of the lab testing marketplace. THE D…

Siemens Acquires Dade, Builds IVD Powerhouse

By Robert Michel | From the Volume XIV No. 11 – August 6, 2007 Issue

CEO SUMMARY: In just 15 months, Siemens AG has pulled out its checkbook three times to spend more than $14 billion to acquire major in vitro diagnostics (IVD) companies. When it closes the purchase of Dade Behring, Siemens will be in the first rank of global IVD manufacturers. It has also…

Misys Health Restructures By Selling Two Divisions

By Robert Michel | From the Volume XIV No. 11 – August 6, 2007 Issue

CEO SUMMARY: Misys Healthcare Systems of London, England, has sold its diagnostic LIS systems to Vista Equity Partners of San Francisco, California, for $381.5 million. The deal raises several questions, particularly for those labs currently running Misys laboratory information systems (L…

GE’s Deal for Abbott IVD Collapses Last Week

By Robert Michel | From the Volume XIV No. 10 – July 16, 2007 Issue

CEO SUMMARY: Both companies have said little about their mutual decision, announced last week, to kill the pending sale of Abbott Diagnostics and Point-of-Care businesses to General Electric. One probability is that GE decided, during due diligence, that its willingness to pay a premium p…

Global Laboratory Trends Dominated by Rising Costs and Labor Shortage

By Robert Michel | From the Volume XIV No. 9 – June 25, 2007 Issue

“The Web has transformed many industries and it’s clearly affected our industry. This trend will help raise the bar in quality and overall performance among laboratories and manufacturers.” —Jim Reid-Anderson Chairman, President, and CEO of Dade Behring…

Lots of IVD Acquisitions as Buyers Spend Money

By Robert Michel | From the Volume XIV No. 5 – April 2, 2007 Issue

CEO SUMMARY: Biggest deal in recent weeks was the $1.55 billion Beckman Coulter paid to acquire BioSite and its Triage BNP test. But the most interesting news may be the entry of 3M Corporation into clinical diagnostics, based on its acquisition of Acolyte Biomedica Ltd.,…

Volume XXVII No. 9 – June 22, 2020

THE NEWS ON THE SEROLOGICAL TEST FRONT is discouraging, even bleak, as THE DARK REPORT analyzes the outcome of the FDA’s own review of 11 tests previously listed as marketable. Only three tests passed the review, and yet a quality control expert consulted by THE DARK REPORT has dim views of the FDA’s testing operation, leading to even more doubts. Also, health insurers are scraping away at mandated COVID-19 test reimbursements, leaving lab revenues once again at their mercy.

See the full table of contents

How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Need A Group Membership? Company Discounts are Available!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

Topics

Visit The Dark Library